You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treat and Extend

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
  • Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
  • (no location specified)
Jun 6, 2023

Diabetic Macular Edema Trial (Faricimab)

Not yet recruiting
  • Diabetic Macular Edema
  • (no location specified)
Jan 20, 2023

Age-Related Macular Degeneration, Pachychoroid Neovasculopathy Trial (Brolucizumab Injection [Beovu])

Not yet recruiting
  • Age-Related Macular Degeneration
  • Pachychoroid Neovasculopathy
  • Brolucizumab Injection [Beovu]
  • (no location specified)
Dec 21, 2022

Exudative Age-Related Macular Degeneration Trial in Chongqing (different degrees of adjustment of the injection interval)

Enrolling by invitation
  • Exudative Age-Related Macular Degeneration
  • different degrees of adjustment of the injection interval
  • Chongqing, China
    The First Affiliated Hospital of Chongqing Medical University
Sep 10, 2022

g Medical Records to Learn More About Treat-and-extend With

Completed
  • Neovascular Age-related Macular Degeneration
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Belgium
    Many Locations
Jun 9, 2022

Age-Related Macular Degeneration Trial in Hong Kong (Brolucizumab, Aflibercept)

Recruiting
  • Age-Related Macular Degeneration
  • Hong Kong, Hong Kong
    Grantham Hospital
Jan 25, 2023

naïve Age-related Macular Degeneration Neovascular Type and

Completed
  • Macular Degeneration
  • Data extraction from medical files
  • Brussels, Belgium
    CHU Brugmann
Mar 7, 2022

naïve Age-related Macular Degeneration of Neovascular Type and

Completed
  • Age-related Macular Degeneration
  • Data extraction from medical files
  • Brussels, Belgium
    CHU Brugmann
Mar 7, 2022

Neovascular Age-Related Macular Degeneration Trial in Worldwide (Ranibizumab, Aflibercept, Port Delivery System with ranibizumab

Suspended
  • Neovascular Age-Related Macular Degeneration
  • Capital Federal, Argentina
  • +9 more
Nov 8, 2022

Wet Age-related Macular Degeneration Trial in Bern (Aflibercept, Brolucizumab, early treat and extend (T&E))

Enrolling by invitation
  • Wet Age-related Macular Degeneration
  • Bern, Switzerland
    Berner Augenklinik am Lindenhofspital
May 13, 2022

Age-related Macular Degeneration (AMD) Trial (brolucizumab)

Withdrawn
  • Age-related Macular Degeneration (AMD)
  • (no location specified)
Sep 21, 2021

Central Retinal Vein Occlusion Trial in Stockholm (Aflibercept, Ranibizumab)

Completed
  • Central Retinal Vein Occlusion
  • Stockholm, Sweden
    St Eriks Eye Hospital
Dec 3, 2020

Age Related Macular Degeneration, Polypoidal Choroidal Vasculopathy Trial in Singapore (Treat and Extend with Aflibercept 2mg,

Completed
Has Results
  • Age Related Macular Degeneration
  • Polypoidal Choroidal Vasculopathy
  • Treat and Extend with Aflibercept 2mg
  • Fixed Dosing with Aflibercept 2mg
  • Singapore, Singpore, Singapore
    Singapore National Eye Centre
Aug 17, 2021

Maximum Treatment Interval With Aflibercept T&E

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept Injection [Eylea]
  • Taipei, Taiwan
    Shin Kong Memorial Wu Ho-Su Hospital
Apr 19, 2022

Retinal Angiomatous Proliferation Trial in Seoul (Aflibercept Injection)

Recruiting
  • Retinal Angiomatous Proliferation
  • Aflibercept Injection
  • Seoul, Korea, Republic of
    Jae Hui Kim
Feb 20, 2021

VA Guided Versus OCT Guided TER Using Aflibercept for Diabetic

Terminated
  • Diabetic Macular Edema
  • OCT guided treatment arm
  • VA guided treatment arm
  • Bern, Switzerland
    Inselspital Bern, Department of Ophthalmology
Mar 15, 2021

Recurrent Neovascular Age-related Macular Degeneration After

Completed
  • Age-related Macular Degeneration
    • Stockholm, Sweden
      St Eriks Eye Hospital
    Dec 9, 2020

    Diabetic Macular Edema Trial in Beverly Hills, West Columbia, Houston (Ranibizumab 0.3 mg intravitreal injection, Guided Laser

    Completed
    Has Results
    • Diabetic Macular Edema
    • Ranibizumab 0.3 mg intravitreal injection
    • Guided Laser Photocoagulation
    • Beverly Hills, California
    • +2 more
    Oct 23, 2020

    Age-related Macular Degeneration Trial in Wuhan, Shanghai (Treat-and-Extend regimen, Pro Re Nata, Conbercept)

    Unknown status
    • Age-related Macular Degeneration
    • Treat-and-Extend regimen
    • +2 more
    • Wuhan, Hubei, China
    • +4 more
    May 17, 2020

    Center-involved Diabetic Macular Edema Trial (Aflibercept Injection [Eylea])

    Completed
    • Center-involved Diabetic Macular Edema
    • Aflibercept Injection [Eylea]
    • (no location specified)
    Feb 25, 2020

    rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

    Completed
    • Age Related Macular Degeneration
    • Bern, Switzerland
    • +1 more
    Nov 28, 2022

    Central Retinal Vein Occlusion Trial in Worldwide (Aflibercept (Eylea, BAY86-5321))

    Completed
    Has Results
    • Central Retinal Vein Occlusion
    • Aflibercept (Eylea, BAY86-5321)
    • Albury, New South Wales, Australia
    • +41 more
    Jun 19, 2020

    Diabetic Macular Edema Trial (FARICIMAB 6 Mg in 0.05 mL INTRAVITREAL INJECTION, SOLUTION [VABYSMO])

    Not yet recruiting
    • Diabetic Macular Edema
    • FARICIMAB 6 Mg in 0.05 mL INTRAVITREAL INJECTION, SOLUTION [VABYSMO]
    • (no location specified)
    Nov 3, 2022

    Canadian Treat and Extend Analysis Trial With Ranibizumab

    Completed
    • wetAMD
    • 0.5 mg Ranibizumab intravitreal injections
    • Calgary, Alberta, Canada
    • +23 more
    Jun 3, 2020

    Neovascular Age-related Macular Degeneration Trial in Nagoya (Intraviteal Ranibizumab 0.5mg)

    Completed
    • Neovascular Age-related Macular Degeneration
    • Intraviteal Ranibizumab 0.5mg
    • Nagoya, Aichi, Japan
    • +1 more
    Aug 17, 2019